Conventional microbiology is being supplemented by molecular rapid diagnostic tests (RDTs), which can increase the efficiency of antimicrobial stewardship (AMS) programs and improve patient outcomes, but “diagnostic stewardship” is an important consideration.
A recent systematic review and meta-analysis of several studies including 5,920 patients found that when combined with AMS intervention, molecular RDTs decreased mortality by 36% in patients